Motif ID | Motif Logo | Scanned Score Distribution | Frequency of Motif | Replicability Score | Evolutionary Conservation Score | Gene Targets | Gene Ontology of CpGMM targets |
---|---|---|---|---|---|---|---|
CG_imr90ipsc_promoter_n_RM_12_178_3 | ![]() |
![]() |
3 | 0.6 | 5.01E-04 | TFR2 | transferrin receptor activity [MF] |
CG_imr90ipsc_promoter_n_RM_12_100_7 | ![]() |
![]() |
3 | 0.6 | 2.77E-04 | CDKN2A, EIF4A3, PASK, CDKN2B | positive regulation of translation [BP], cyclin-dependent protein kinase inhibitor activity [MF] |
CG_imr90ipsc_promoter_n_RM_12_148_7 | ![]() |
![]() |
8 | 1.0 | 5.65E-04 | CDK5 | acetylcholine receptor activator activity [MF] |
CG_imr90ipsc_promoter_n_RM_14_12_5 | ![]() |
![]() |
10 | 1.0 | 4.67E-04 | MGEA5, CENPJ, RNGTT, SLC30A3 | zinc transporting ATPase activity [MF], gamma-tubulin small complex [CC], mRNA guanylyltransferase activity [MF], negative regulation of cardiac muscle adaptation [BP], polynucleotide 5'-phosphatase activity [MF] |
CG_imr90ipsc_promoter_n_RM_12_50_6 | ![]() |
![]() |
7 | 1.0 | 4.33E-04 | HSPA5, LUZP1 | neural fold bending [BP], regulation of protein folding in endoplasmic reticulum [BP] |
CG_imr90ipsc_promoter_n_RM_12_108_4 | ![]() |
![]() |
2 | 0.4 | 3.75E-04 | CACNA1F, IRF7 | regulation of monocyte differentiation [BP], voltage-gated calcium channel complex [CC] |
CG_imr90ipsc_promoter_n_RM_12_52_5 | ![]() |
![]() |
4 | 0.8 | 3.06E-04 | LCAT | phosphatidylcholine-sterol O-acyltransferase activity [MF] |
CG_imr90ipsc_promoter_n_RM_12_42_4 | ![]() |
![]() |
3 | 0.6 | 2.05E-04 | GLI3, PCID2, ZFP36L1, SCRIB | regulation of mRNA stability [BP], thymocyte apoptotic process [BP], mammary gland duct morphogenesis [BP] |
CG_imr90ipsc_promoter_n_RM_12_144_7 | ![]() |
![]() |
3 | 0.6 | 5.03E-04 | MSRB1 | methionine-R-sulfoxide reductase activity [MF] |
CG_imr90ipsc_promoter_n_RM_12_146_6 | ![]() |
![]() |
5 | 1.0 | 3.34E-04 | SLC37A4, ST6GALNAC4 | glucose-6-phosphate transmembrane transporter activity [MF], (alpha-N-acetylneuraminyl-2,3-beta-galactosyl-1,3)-N-acetyl-galactosaminide 6-alpha-sialyltransferase activity [MF] |
CG_imr90ipsc_promoter_n_RM_14_11_3 | ![]() |
![]() |
4 | 0.8 | 6.51E-04 | RBBP7, SOX10 | cellular heat acclimation [BP], extrinsic to mitochondrial outer membrane [CC] |
CG_imr90ipsc_promoter_n_RM_12_171_4 | ![]() |
![]() |
2 | 0.4 | 2.88E-04 | MLXIPL | glucose mediated signaling pathway [BP], carbohydrate response element binding [MF] |
CG_imr90ipsc_promoter_n_RM_12_122_9 | ![]() |
![]() |
5 | 1.0 | 3.13E-04 | LDB1 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [BP], histone H3-K4 acetylation [BP] |
CG_imr90ipsc_promoter_n_RM_12_174_6 | ![]() |
![]() |
4 | 0.6 | 3.49E-04 | IFNA2, NRP1, NACC2 | negative regulation of interleukin-5 secretion [BP], negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter [BP], positive regulation of cytokine activity [BP], negative regulation of interleukin-13 secretion [BP] |
CG_imr90ipsc_promoter_n_RM_12_143_7 | ![]() |
![]() |
4 | 0.8 | 3.61E-04 | DEDD2 | apoptotic nuclear changes [BP] |
CG_imr90ipsc_promoter_n_RM_12_12_7 | ![]() |
![]() |
5 | 1.0 | 2.56E-04 | G6PD, SIX1, PDE4DIP, PRKACA, JAK3, PRKRA, NES, UBR4, CENPJ | centrosome [CC], cytoskeleton [CC], G2/M transition of mitotic cell cycle [BP], middle ear morphogenesis [BP] |
CG_imr90ipsc_promoter_n_RM_12_168_3 | ![]() |
![]() |
4 | 0.6 | 2.47E-04 | MED16, TOB2, SALL1 | forelimb morphogenesis [BP], limb development [BP], vitamin D receptor binding [MF] |
CG_imr90ipsc_promoter_n_RM_12_67_8 | ![]() |
![]() |
6 | 1.0 | 3.45E-04 | SALL1 | forelimb morphogenesis [BP] |
CG_imr90ipsc_promoter_n_RM_12_173_4 | ![]() |
![]() |
3 | 0.6 | 2.87E-04 | SP3, RUNX1, HRAS | organ morphogenesis [BP], definitive hemopoiesis [BP] |
CG_imr90ipsc_promoter_n_RM_12_97_9 | ![]() |
![]() |
2 | 0.4 | 4.12E-04 | FEZF1, FEZF2, HCN1, PSME4, MAML3, ATPAF2 | RNA polymerase II core promoter proximal region sequence-specific DNA binding [MF], sodium channel activity [MF], nuclear speck [CC], forebrain anterior/posterior pattern specification [BP] |
CG_imr90ipsc_promoter_n_RM_12_14_5 | ![]() |
![]() |
3 | 0.6 | 3.61E-04 | BAP1, E2F7 | positive regulation of DNA endoreduplication [BP], monoubiquitinated histone H2A deubiquitination [BP], PR-DUB complex [CC] |
CG_imr90ipsc_promoter_n_RM_12_21_6 | ![]() |
![]() |
7 | 0.8 | 3.45E-04 | CEBPA, MAP6D1, AKT1, MPPE1, BCAR1, IGF2 | positive regulation of blood vessel endothelial cell migration [BP], positive regulation of fat cell differentiation [BP], positive regulation of glycogen biosynthetic process [BP], cis-Golgi network [CC], regulation of glycogen biosynthetic process [BP], ossification [BP], positive regulation of endothelial cell migration [BP], positive regulation of glucose metabolic process [BP], mitochondrion organization [BP] |
CG_imr90ipsc_promoter_n_RM_12_198_4 | ![]() |
![]() |
3 | 0.6 | 4.44E-04 | SIX2, SIX4 | embryonic cranial skeleton morphogenesis [BP] |
CG_imr90ipsc_promoter_n_RM_12_56_6 | ![]() |
![]() |
5 | 1.0 | 2.13E-04 | SNUPN, ITPK1 | inositol tetrakisphosphate 1-kinase activity [MF], inositol-1,3,4-trisphosphate 6-kinase activity [MF], snRNA import into nucleus [BP], inositol-1,3,4-trisphosphate 5-kinase activity [MF] |
CG_imr90ipsc_promoter_n_RM_12_81_3 | ![]() |
![]() |
3 | 0.6 | 2.85E-04 | BAD | cellular response to chromate [BP] |
CG_imr90ipsc_promoter_n_RM_12_93_3 | ![]() |
![]() |
4 | 0.6 | 1.23E-04 | C5, CIZ1 | negative regulation of macrophage chemotaxis [BP], C5a anaphylatoxin chemotactic receptor binding [MF], maintenance of nucleus location [BP] |
CG_imr90ipsc_promoter_n_RM_14_24_2 | ![]() |
![]() |
3 | 0.4 | 6.23E-04 | ABCC9, PRKRA | sulfonylurea receptor activity [MF], production of siRNA involved in RNA interference [BP], ATP-sensitive potassium channel complex [CC] |
CG_imr90ipsc_promoter_n_RM_12_152_5 | ![]() |
![]() |
4 | 0.8 | 2.34E-04 | HID1 | extrinsic to Golgi membrane [CC] |
CG_imr90ipsc_promoter_n_RM_12_167_5 | ![]() |
![]() |
4 | 0.8 | 2.34E-04 | IL5RA, IDH2 | isocitrate dehydrogenase (NADP+) activity [MF], interleukin-5-mediated signaling pathway [BP], glyoxylate cycle [BP], interleukin-5 receptor activity [MF] |
CG_imr90ipsc_promoter_n_RM_12_110_3 | ![]() |
![]() |
2 | 0.4 | 2.71E-04 | KIF17, SMAD7 | cellular protein complex localization [BP], protein complex localization [BP] |
CG_imr90ipsc_promoter_n_RM_12_165_13 | ![]() |
![]() |
5 | 0.8 | 2.13E-04 | BAG6, USP45 | ubiquitin-dependent protein catabolic process [BP], negative regulation of proteasomal ubiquitin-dependent protein catabolic process [BP] |
CG_imr90ipsc_promoter_n_RM_14_22_2 | ![]() |
![]() |
2 | 0.4 | 4.94E-04 | HYAL1 | hyaluranon cable [CC] |
CG_imr90ipsc_promoter_n_RM_14_2_1 | ![]() |
![]() |
4 | 0.6 | 3.46E-04 | NOP14, ADAT1 | endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [BP], Noc4p-Nop14p complex [CC], endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [BP], tRNA-specific adenosine deaminase activity [MF] |
CG_imr90ipsc_promoter_n_RM_12_161_6 | ![]() |
![]() |
3 | 0.6 | 2.43E-04 | BAG6, C1orf86 | polyubiquitin binding [MF] |
CG_imr90ipsc_promoter_n_RM_12_103_2 | ![]() |
![]() |
3 | 0.6 | 2.10E-04 | BCOR, HEY1, TFAP2A | atrioventricular valve formation [BP], optic vesicle morphogenesis [BP], negative regulation of histone H3-K36 methylation [BP], optic cup structural organization [BP] |
CG_imr90ipsc_promoter_n_RM_12_29_5 | ![]() |
![]() |
4 | 0.8 | 3.13E-04 | PON3 | dihydrocoumarin hydrolase activity [MF], phenylacetate catabolic process [BP], 3,4-dihydrocoumarin hydrolase activity [MF] |
CG_imr90ipsc_promoter_n_RM_12_33_2 | ![]() |
![]() |
4 | 0.6 | 3.54E-04 | INSRR, BCOR, SLC35B2 | 3'-phosphoadenosine 5'-phosphosulfate transport [BP], negative regulation of histone H3-K4 methylation [BP], negative regulation of histone H3-K36 methylation [BP], negative regulation of tooth mineralization [BP], 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity [MF], cellular response to alkalinity [BP] |
CG_imr90ipsc_promoter_n_RM_12_239_12 | ![]() |
![]() |
6 | 1.0 | 1.71E-04 | GPLD1 | GPI anchor release [BP], cellular response to triglyceride [BP] |
CG_imr90ipsc_promoter_n_RM_12_150_9 | ![]() |
![]() |
3 | 0.6 | 2.67E-04 | EFEMP2, CASK, LAMA1 | basement membrane [CC] |
CG_imr90ipsc_promoter_n_RM_12_66_4 | ![]() |
![]() |
2 | 0.4 | 3.59E-04 | CDK5 | axon extension [BP], acetylcholine receptor activator activity [MF] |
CG_imr90ipsc_promoter_n_RM_12_91_5 | ![]() |
![]() |
7 | 1.0 | 1.97E-04 | ANKRD11, ICMT | protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity [MF], in utero embryonic development [BP] |
CG_imr90ipsc_promoter_n_RM_14_26_3 | ![]() |
![]() |
3 | 0.4 | 2.54E-04 | TNK2, ACTN1, GLI3, EXTL2, GRIN2C, CITED2, STX1A | cell junction [CC], cranial nerve morphogenesis [BP], anterior semicircular canal development [BP], lambdoid suture morphogenesis [BP], alpha-1,4-N-acetylgalactosaminyltransferase activity [MF], adherens junction [CC], histone acetyltransferase binding [MF], protein domain specific binding [MF], lateral semicircular canal development [BP], sagittal suture morphogenesis [BP], myosin head/neck binding [MF], lateral ganglionic eminence cell proliferation [BP] |
CG_imr90ipsc_promoter_n_RM_12_31_9 | ![]() |
![]() |
8 | 1.0 | 1.93E-04 | HIBCH, ADPGK, MKX, PDGFA | tendon sheath development [BP], ADP-specific glucokinase activity [MF], regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling [BP], 3-hydroxyisobutyryl-CoA hydrolase activity [MF] |
CG_imr90ipsc_promoter_n_RM_12_135_5 | ![]() |
![]() |
4 | 0.8 | 3.10E-04 | PLAUR, INTS1, NEUROD2 | U-plasminogen activator receptor activity [MF], cerebellar cortex development [BP], U2 snRNA 3'-end processing [BP] |
CG_imr90ipsc_promoter_n_RM_12_225_3 | ![]() |
![]() |
3 | 0.6 | 3.12E-04 | KDSR | 3-dehydrosphinganine reductase activity [MF], 3-keto-sphinganine metabolic process [BP] |
CG_imr90ipsc_promoter_n_RM_12_140_5 | ![]() |
![]() |
3 | 0.4 | 2.85E-04 | FGF8, SMAD7, MAMSTR, PHIP, SHANK1, BRCA1 | positive regulation of histone H4-K16 acetylation [BP], determination of affect [BP], somatostatin receptor binding [MF], positive regulation of histone H3-K9 acetylation [BP], cell migration involved in mesendoderm migration [BP], habituation [BP], artery morphogenesis [BP], positive regulation of mitosis [BP], positive regulation of transcription from RNA polymerase II promoter [BP], positive regulation of histone H4-K20 methylation [BP], positive regulation of gene expression [BP], regulation of transcription from RNA polymerase II promoter [BP] |
CG_imr90ipsc_promoter_n_RM_12_209_4 | ![]() |
![]() |
5 | 0.8 | 3.03E-04 | GNL1, BCL6, HOXA7 | GTP catabolic process [BP], negative regulation of cell-matrix adhesion [BP] |
CG_imr90ipsc_promoter_n_RM_12_111_3 | ![]() |
![]() |
3 | 0.6 | 8.04E-05 | COL16A1, MYO5B | water transport [BP], collagen type XVI [CC] |
CG_imr90ipsc_promoter_n_RM_12_213_3 | ![]() |
![]() |
3 | 0.6 | 1.34E-04 | PDGFA, SIAH2, SOS1, LAMA1, PPP2CA, PLA2G16, PLAG1, ARHGEF11 | regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling [BP], branching involved in salivary gland morphogenesis [BP], 1-acyl-2-lysophosphatidylserine acylhydrolase activity [MF], axon guidance [BP], phosphatidylserine 1-acylhydrolase activity [MF], regulation of protein autophosphorylation [BP], gland morphogenesis [BP] |
CG_imr90ipsc_promoter_n_RM_14_4_1 | ![]() |
![]() |
3 | 0.4 | 4.00E-04 | LDB1 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [BP], histone H3-K4 acetylation [BP], positive regulation of hemoglobin biosynthetic process [BP] |
CG_imr90ipsc_promoter_n_RM_12_211_5 | ![]() |
![]() |
3 | 0.6 | 2.73E-04 | G6PD | negative regulation of protein glutathionylation [BP] |
CG_imr90ipsc_promoter_n_RM_12_194_4 | ![]() |
![]() |
4 | 0.8 | 8.66E-05 | RFWD2, ARHGEF2, ZFHX3, PGLYRP1, FBXO5, SNAI3, IVNS1ABP, OPLAH, WT1 | negative regulation of metanephric glomerular mesangial cell proliferation [BP], spindle assembly involved in female meiosis I [BP], nucleoplasm [CC], inhibition of mitotic anaphase-promoting complex activity [BP], 5-oxoprolinase (ATP-hydrolyzing) activity [MF], transcription factor complex [CC], zinc ion binding [MF] |
CG_imr90ipsc_promoter_n_RM_12_113_6 | ![]() |
![]() |
4 | 0.6 | 4.74E-04 | RAB3D, LGI3, DAB1, PTCH1, FGFR2, NRARP | mammary gland bud formation [BP], response to chlorate [BP], mesenchymal cell differentiation involved in lung development [BP], fibroblast growth factor receptor signaling pathway involved in mammary gland specification [BP], positive regulation of Wnt receptor signaling pathway [BP], cell-cell adhesion involved in neuronal-glial interactions involved in cerebral cortex radial glia guided migration [BP], regulation of smoothened signaling pathway [BP], orbitofrontal cortex development [BP], squamous basal epithelial stem cell differentiation involved in prostate gland acinus development [BP], branch elongation involved in salivary gland morphogenesis [BP], smoothened signaling pathway [BP], fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow [BP], mammary gland duct morphogenesis [BP], fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development [BP], radial glia guided migration of Purkinje cell [BP], fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow [BP], fibroblast growth factor receptor signaling pathway involved in hemopoiesis [BP], positive regulation of canonical Wnt receptor signaling pathway [BP], regulation of multicellular organism growth [BP], cerebellum structural organization [BP], coronal suture morphogenesis [BP], embryonic pattern specification [BP], regulation of osteoblast differentiation [BP], regulation of exocytosis [BP], neural plate axis specification [BP] |
CG_imr90ipsc_promoter_n_RM_12_64_6 | ![]() |
![]() |
4 | 0.8 | 1.28E-04 | CDK5, HDAC4 | neuromuscular junction [CC], acetylcholine receptor activator activity [MF] |
CG_imr90ipsc_promoter_n_RM_12_79_4 | ![]() |
![]() |
3 | 0.6 | 3.32E-04 | TBX18, WNT10B, JUP, MTHFR, TLE3 | positive regulation of anagen [BP], negative regulation of canonical Wnt receptor signaling pathway involved in neural plate anterior/posterior pattern formation [BP], myoblast cell differentiation involved in skeletal muscle regeneration [BP], Wnt receptor signaling pathway [BP], positive regulation of canonical Wnt receptor signaling pathway [BP], gamma-catenin-TCF7L2 complex [CC], structural constituent of cell wall [MF], canonical Wnt receptor signaling pathway [BP], methylenetetrahydrofolate reductase (NADPH) activity [MF] |
CG_imr90ipsc_promoter_n_RM_14_8_1 | ![]() |
![]() |
3 | 0.6 | 1.80E-05 | ZNF44, ZNF799, ZNF442, ZNF443, ZNF823 | transcription, DNA-dependent [BP], DNA binding [MF], regulation of transcription, DNA-dependent [BP], zinc ion binding [MF] |
CG_imr90ipsc_promoter_n_RM_12_124_10 | ![]() |
![]() |
6 | 1.0 | 3.98E-04 | ICMT, OCA2, MTFMT | protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity [MF], arsenite transport [BP], methionyl-tRNA formyltransferase activity [MF], tyrosine transport [BP], L-tyrosine transmembrane transporter activity [MF] |
CG_imr90ipsc_promoter_n_RM_12_20_3 | ![]() |
![]() |
2 | 0.4 | 2.42E-04 | EN1, GAS1 | dorsal/ventral pattern formation [BP], anchored to plasma membrane [CC] |
CG_imr90ipsc_promoter_n_RM_12_74_6 | ![]() |
![]() |
3 | 0.6 | 1.35E-04 | ANKLE2 | mitotic nuclear envelope reassembly [BP] |
CG_imr90ipsc_promoter_n_RM_12_68_2 | ![]() |
![]() |
3 | 0.6 | 2.46E-04 | KIF21A, PHYH, CAMSAP1, LDB1 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [BP], histone H3-K4 acetylation [BP], microtubule [CC], phytanoyl-CoA dioxygenase activity [MF] |
CG_imr90ipsc_promoter_n_RM_12_186_3 | ![]() |
![]() |
4 | 0.8 | 1.33E-04 | OAT | ornithine-oxo-acid transaminase activity [MF] |
CG_imr90ipsc_promoter_n_RM_12_193_5 | ![]() |
![]() |
3 | 0.6 | 2.70E-04 | ICMT | protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity [MF] |
CG_imr90ipsc_promoter_n_RM_12_232_6 | ![]() |
![]() |
4 | 0.8 | 1.31E-04 | TGFB1, PTK2, EFNB2 | negative regulation of cell-cell adhesion [BP], positive regulation of phosphatidylinositol 3-kinase activity [BP], endothelial cell migration [BP], ephrin receptor signaling pathway [BP] |
CG_imr90ipsc_promoter_n_RM_12_26_3 | ![]() |
![]() |
6 | 0.8 | 3.37E-04 | WNT11, NKX3-1 | protein kinase activator activity [MF] |
CG_imr90ipsc_promoter_n_RM_12_107_5 | ![]() |
![]() |
5 | 0.8 | 2.88E-04 | CEBPD, FOXA1, NKX3-2, TRIP11, HOXA2, NR3C1 | sequence-specific DNA binding [MF], transcription from RNA polymerase II promoter [BP], middle ear morphogenesis [BP] |
CG_imr90ipsc_promoter_n_RM_12_184_4 | ![]() |
![]() |
6 | 1.0 | 2.32E-04 | GLI3, POLE, SMC1A | anterior semicircular canal development [BP], lambdoid suture morphogenesis [BP], lateral semicircular canal development [BP], sagittal suture morphogenesis [BP], lateral ganglionic eminence cell proliferation [BP], chromatin binding [MF] |
CG_imr90ipsc_promoter_n_RM_12_199_4 | ![]() |
![]() |
5 | 1.0 | 3.11E-04 | MNX1, LUZP1, HOXA1, PRDM14 | cell morphogenesis [BP], motor neuron axon guidance [BP], artery development [BP] |
CG_imr90ipsc_promoter_n_RM_12_22_5 | ![]() |
![]() |
2 | 0.4 | 5.38E-05 | ACVR1C, RAB17, OXTR, CKM | nodal binding [MF], immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor [BP], negative regulation of chorionic trophoblast cell proliferation [BP], oxytocin receptor activity [MF], activin receptor complex [CC], response to anoxia [BP], phosphocreatine biosynthetic process [BP], positive regulation of norepinephrine secretion [BP], regulation of synapse assembly [BP] |
CG_imr90ipsc_promoter_n_RM_12_190_3 | ![]() |
![]() |
7 | 1.0 | 4.80E-04 | NCAPD3, HSPA5 | nuclear condensin complex [CC], regulation of protein folding in endoplasmic reticulum [BP] |
CG_imr90ipsc_promoter_n_RM_16_2_1 | ![]() |
![]() |
2 | 0.4 | 9.92E-04 | TRIM27 | negative regulation of interleukin-2 secretion [BP] |
CG_imr90ipsc_promoter_n_RM_12_154_10 | ![]() |
![]() |
5 | 1.0 | 1.03E-04 | IL6ST | interleukin-11 binding [MF], negative regulation of interleukin-6-mediated signaling pathway [BP], interleukin-11 receptor activity [MF], ciliary neurotrophic factor receptor complex [CC], interleukin-27-mediated signaling pathway [BP] |
CG_imr90ipsc_promoter_n_RM_12_39_3 | ![]() |
![]() |
5 | 0.8 | 3.94E-04 | TOP1MT, HMGB2 | DNA topological change [BP] |
CG_imr90ipsc_promoter_n_RM_12_142_6 | ![]() |
![]() |
7 | 1.0 | 5.72E-04 | HIRA, CBX8, MUC1 | nuclear chromatin [CC] |
CG_imr90ipsc_promoter_n_RM_12_54_11 | ![]() |
![]() |
6 | 1.0 | 5.10E-04 | ZNF521, AMBRA1, CATSPER1, GSK3B, GNPTAB | positive regulation of Rac GTPase activity [BP], cell differentiation [BP] |
CG_imr90ipsc_promoter_n_RM_12_24_4 | ![]() |
![]() |
8 | 1.0 | 3.97E-04 | HOMEZ, CALCOCO1, SP3, PABPC4, PARK2, DVL2, POLE, ZIC5, SGMS1, CHFR, HIP1, C2CD2 | protein domain specific binding [MF], nucleus [CC] |
CG_imr90ipsc_promoter_n_RM_12_69_3 | ![]() |
![]() |
4 | 0.8 | 2.72E-04 | GLI3 | lambdoid suture morphogenesis [BP], sagittal suture morphogenesis [BP], lateral semicircular canal development [BP], lateral ganglionic eminence cell proliferation [BP], anterior semicircular canal development [BP] |
CG_imr90ipsc_promoter_n_RM_14_5_5 | ![]() |
![]() |
9 | 1.0 | 2.93E-04 | DTYMK | nucleoside monophosphate phosphorylation [BP] |
CG_imr90ipsc_promoter_n_RM_12_189_5 | ![]() |
![]() |
2 | 0.4 | 3.60E-04 | FUCA2 | alpha-L-fucosidase activity [MF] |
CG_imr90ipsc_promoter_n_RM_12_182_2 | ![]() |
![]() |
2 | 0.4 | 4.73E-04 | PCYT2, SALL1, ALG3 | dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity [MF], inductive cell-cell signaling [BP], ethanolamine-phosphate cytidylyltransferase activity [MF] |
CG_imr90ipsc_promoter_n_RM_12_76_4 | ![]() |
![]() |
4 | 0.6 | 5.46E-05 | POU4F1, SMG6, FLCN, TAF6, EEF1A1 | ventricular compact myocardium morphogenesis [BP], proprioception involved in equilibrioception [BP], habenula development [BP], negative regulation of energy homeostasis [BP], gene expression [BP], RNA metabolic process [BP], negative regulation of ATP biosynthetic process [BP] |
CG_imr90ipsc_promoter_n_RM_12_202_4 | ![]() |
![]() |
2 | 0.4 | 6.09E-04 | DBN1, TCF4, EGR2 | rhombomere 3 formation [BP], rhombomere 5 formation [BP], sequence-specific DNA binding RNA polymerase recruiting transcription factor activity [MF], TFIIB-class binding transcription factor activity [MF], TFIIB-class transcription factor binding [MF], cell communication by chemical coupling [BP], regulation of neuronal synaptic plasticity [BP] |
CG_imr90ipsc_promoter_n_RM_14_7_2 | ![]() |
![]() |
2 | 0.4 | 3.52E-04 | ARRDC3, CALCR | positive regulation of adrenergic receptor signaling pathway [BP], calcitonin binding [MF], negative regulation of heat generation [BP], negative regulation of locomotion involved in locomotory behavior [BP], beta-3 adrenergic receptor binding [MF] |
CG_imr90ipsc_promoter_n_RM_12_227_4 | ![]() |
![]() |
5 | 1.0 | 2.88E-04 | UCN, LPHN1, STRN3, RGS10, MYH10 | neuron projection [CC], neuronal cell body [CC], axon [CC], dendrite [CC], response to pain [BP] |
CG_imr90ipsc_promoter_n_RM_12_180_5 | ![]() |
![]() |
7 | 1.0 | 3.24E-04 | ALG3, PRICKLE1 | dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity [MF], negative regulation of cardiac muscle cell myoblast differentiation [BP] |
CG_imr90ipsc_promoter_n_RM_12_219_6 | ![]() |
![]() |
8 | 1.0 | 3.55E-04 | SMAD7, GLI3, SALL1, SLIT1, MYOF, WNT7B, MKI67 | ureteric bud development [BP], spinal cord development [BP], negative regulation of smoothened signaling pathway [BP], cellular response to heat [BP], negative regulation of alpha-beta T cell differentiation [BP], thymocyte apoptotic process [BP], beta-catenin binding [MF], smoothened signaling pathway [BP], metanephros development [BP], forebrain regionalization [BP] |
CG_imr90ipsc_promoter_n_RM_12_133_5 | ![]() |
![]() |
5 | 1.0 | 4.41E-04 | RALGAPA2 | GTPase activator activity [MF] |
CG_imr90ipsc_promoter_n_RM_12_195_3 | ![]() |
![]() |
5 | 0.8 | 3.33E-04 | MLL2, PCGF6, RCOR2, REV3L, CHTF8, ELMSAN1, CHD5 | DNA binding [MF] |
CG_imr90ipsc_promoter_n_RM_12_28_3 | ![]() |
![]() |
4 | 0.8 | 2.99E-04 | YBX2, MSRB1 | methionine-R-sulfoxide reductase activity [MF], translational attenuation [BP] |
CG_imr90ipsc_promoter_n_RM_12_114_7 | ![]() |
![]() |
4 | 0.8 | 2.30E-04 | BARHL2, ROBO1, DNAJC7, ST13, DVL1, GFRA1, CDK5, GAS1, FGFR2, CSNK2A2, SCN3B, NKX6-1, FOXA2 | axonogenesis [BP], neuron projection development [BP], chaperone cofactor-dependent protein refolding [BP], developmental growth [BP], axon extension [BP], detection of glucose [BP], oligodendrocyte differentiation [BP], synaptic vesicle transport [BP], axon guidance [BP], neuron differentiation [BP], dorsal/ventral neural tube patterning [BP], cell fate commitment [BP] |
CG_imr90ipsc_promoter_n_RM_14_1_2 | ![]() |
![]() |
9 | 1.0 | 2.91E-04 | TRPT1, YIF1A, C19orf10, DHCR7 | tRNA 2'-phosphotransferase activity [MF], activation of signaling protein activity involved in unfolded protein response [BP], endoplasmic reticulum-Golgi intermediate compartment [CC], 7-dehydrocholesterol reductase activity [MF] |
CG_imr90ipsc_promoter_n_RM_12_197_6 | ![]() |
![]() |
4 | 0.8 | 2.45E-04 | COPB1 | intra-Golgi vesicle-mediated transport [BP] |
CG_imr90ipsc_promoter_n_RM_12_230_3 | ![]() |
![]() |
3 | 0.6 | 2.82E-04 | TUBB4A, AXIN2, CDK6, TSPAN2 | negative regulation of osteoblast differentiation [BP], myelin sheath [CC] |
CG_imr90ipsc_promoter_n_RM_12_32_9 | ![]() |
![]() |
3 | 0.6 | 3.80E-04 | LEF1, FBXW4, ACD, SP8 | embryonic limb morphogenesis [BP] |
CG_imr90ipsc_promoter_n_RM_12_9_7 | ![]() |
![]() |
6 | 1.0 | 3.03E-04 | AKR1B1, SMC1A | glyceraldehyde oxidoreductase activity [MF], cohesin core heterodimer [CC] |
CG_imr90ipsc_promoter_n_RM_12_121_6 | ![]() |
![]() |
6 | 1.0 | 3.36E-04 | SFRP2 | negative regulation of dermatome development [BP], metalloenzyme activator activity [MF] |
CG_imr90ipsc_promoter_n_RM_12_5_4 | ![]() |
![]() |
3 | 0.6 | 3.74E-04 | SHH, CXCR4, SIX1, FIGNL1, WWTR1 | osteoblast differentiation [BP], ureter smooth muscle cell differentiation [BP], positive regulation of oligodendrocyte differentiation [BP], positive regulation of mesenchymal cell proliferation involved in ureter development [BP], metanephric mesenchyme development [BP], thymus development [BP], thyroid gland development [BP] |
CG_imr90ipsc_promoter_n_RM_12_137_2 | ![]() |
![]() |
3 | 0.6 | 3.04E-04 | SRSF9, MCL1, DBT, CTDSP2, XBP1, TLE1 | nucleoplasm [CC], serotonin secretion, neurotransmission [BP], dihydrolipoyllysine-residue (2-methylpropanoyl)transferase activity [MF], negative regulation of anoikis [BP], epithelial cell maturation involved in salivary gland development [BP] |
CG_imr90ipsc_promoter_n_RM_14_19_1 | ![]() |
![]() |
2 | 0.4 | 2.90E-04 | PDGFA | negative regulation of phosphatidylinositol biosynthetic process [BP], regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling [BP], positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway [BP] |
CG_imr90ipsc_promoter_n_RM_12_215_5 | ![]() |
![]() |
5 | 0.8 | 3.30E-04 | PCGF2, PCGF6, DNMT3A | S-adenosylhomocysteine metabolic process [BP], nuclear heterochromatin [CC], PRC1 complex [CC], PcG protein complex [CC] |
CG_imr90ipsc_promoter_n_RM_12_208_2 | ![]() |
![]() |
9 | 1.0 | 1.46E-04 | GFPT2, ICMT, ALG2 | protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity [MF], protein glycosylation in endoplasmic reticulum [BP], post-translational protein modification [BP], dolichol-linked oligosaccharide biosynthetic process [BP], GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity [MF] |
CG_imr90ipsc_promoter_n_RM_12_84_4 | ![]() |
![]() |
6 | 1.0 | 1.14E-04 | SLC7A10, ABCB6, LONP1 | mitochondrial heavy strand promoter anti-sense binding [MF], heme-transporting ATPase activity [MF], D-alanine transport [BP], oxidation-dependent protein catabolic process [BP], mitochondrial light strand promoter anti-sense binding [MF] |
CG_imr90ipsc_promoter_n_RM_12_30_6 | ![]() |
![]() |
6 | 0.8 | 2.52E-04 | IRF7, USP45, COLEC12, USP49, CASP6 | pattern recognition receptor signaling pathway [BP], protein acetylation [BP], cysteine-type peptidase activity [MF] |
CG_imr90ipsc_promoter_n_RM_14_9_7 | ![]() |
![]() |
10 | 0.8 | 5.11E-04 | HIRA, SOX10, CALCOCO1, RXRG, ZFHX3, TFAP2A, MAMSTR, HOXA1, CNTFR, NKX2-4, NFIB | RNA polymerase II transcription factor binding transcription factor activity [MF], RNA polymerase II transcription corepressor activity [MF], sequence-specific DNA binding transcription factor activity [MF], sequence-specific DNA binding [MF], sequence-specific DNA binding RNA polymerase II transcription factor activity [MF], positive regulation of transcription from RNA polymerase II promoter [BP], skeletal muscle organ development [BP], transcription from RNA polymerase II promoter [BP], RNA polymerase II distal enhancer sequence-specific DNA binding [MF], regulation of transcription from RNA polymerase II promoter [BP] |
CG_imr90ipsc_promoter_n_RM_12_65_2 | ![]() |
![]() |
2 | 0.4 | 1.64E-04 | TENM4, FOXA2 | positive regulation of gastrulation [BP], regulation of transcription from RNA polymerase II promoter involved in detection of glucose [BP], central nervous system myelin formation [BP], negative regulation of detection of glucose [BP], negative regulation of transcription from RNA polymerase II promoter by glucose [BP], gastrulation with mouth forming second [BP] |
CG_imr90ipsc_promoter_n_RM_12_115_10 | ![]() |
![]() |
5 | 1.0 | 2.65E-04 | RDX | actin filament capping [BP] |
CG_imr90ipsc_promoter_n_RM_12_212_7 | ![]() |
![]() |
2 | 0.4 | 3.02E-04 | NKX3-2, COL11A2, COL1A1, ONECUT1 | spleen development [BP], collagen fibril organization [BP], cartilage development [BP] |
CG_imr90ipsc_promoter_n_RM_12_117_10 | ![]() |
![]() |
5 | 1.0 | 2.64E-04 | FGF8, HOXB3 | cell migration involved in mesendoderm migration [BP], thyroid gland development [BP] |
CG_imr90ipsc_promoter_n_RM_12_1_4 | ![]() |
![]() |
5 | 1.0 | 3.01E-04 | ZC3H8, KIAA0430, ACD, SCAF4 | RNA binding [MF], positive regulation of single-stranded telomeric DNA binding [BP] |
CG_imr90ipsc_promoter_n_RM_12_112_4 | ![]() |
![]() |
5 | 1.0 | 2.32E-04 | CDK5, SPAG8, CSDA | positive regulation of cytoplasmic translation [BP], positive regulation of protein binding [BP], acetylcholine receptor activator activity [MF] |
CG_imr90ipsc_promoter_n_RM_12_63_2 | ![]() |
![]() |
6 | 1.0 | 3.71E-04 | PAX6, DLL1 | cell fate determination [BP] |
CG_imr90ipsc_promoter_n_RM_12_27_4 | ![]() |
![]() |
3 | 0.6 | 1.28E-04 | SYNE4 | integral to nuclear outer membrane [CC] |
CG_imr90ipsc_promoter_n_RM_12_106_5 | ![]() |
![]() |
4 | 0.6 | 2.03E-04 | COL12A1 | collagen type XII [CC] |
CG_imr90ipsc_promoter_n_RM_12_217_5 | ![]() |
![]() |
4 | 0.8 | 3.75E-04 | HSPD1, TNIP2 | positive regulation of macrophage activation [BP] |
CG_imr90ipsc_promoter_n_RM_12_101_4 | ![]() |
![]() |
4 | 0.8 | 1.86E-04 | CACNA1S, MYH9 | myoblast fusion [BP] |
CG_imr90ipsc_promoter_n_RM_16_1_5 | ![]() |
![]() |
9 | 1.0 | 4.04E-04 | ZFHX3, TOP2A, PDE4DIP | enzyme binding [MF] |
CG_imr90ipsc_promoter_n_RM_12_214_2 | ![]() |
![]() |
1 | 0.2 | 2.80E-04 | NUDT18, NACC2 | GDP catabolic process [BP], 8-oxo-dGDP phosphatase activity [MF], negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter [BP], 8-oxo-GDP phosphatase activity [MF], dADP catabolic process [BP], dGDP catabolic process [BP], 8-hydroxy-dADP phosphatase activity [MF] |
CG_imr90ipsc_promoter_n_RM_12_60_6 | ![]() |
![]() |
8 | 0.8 | 2.85E-04 | ERCC1, NCL, SBDS | mitotic spindle stabilization [BP], protein C-terminus binding [MF] |
CG_imr90ipsc_promoter_n_RM_12_92_6 | ![]() |
![]() |
3 | 0.6 | 2.75E-04 | FBXO21, MAP4K3, CXCR4, USP45 | JNK cascade [BP], ubiquitin-dependent protein catabolic process [BP], myelin maintenance [BP] |
CG_imr90ipsc_promoter_n_RM_12_86_8 | ![]() |
![]() |
4 | 0.8 | 4.20E-04 | TFAP4, HMGB2 | transcription regulatory region DNA binding [MF] |
CG_imr90ipsc_promoter_n_RM_12_185_5 | ![]() |
![]() |
4 | 0.8 | 1.75E-04 | ANXA2, LTBP2, MEFV | extracellular vesicular exosome [CC], negative regulation of macrophage inflammatory protein 1 alpha production [BP] |
CG_imr90ipsc_promoter_n_RM_12_7_3 | ![]() |
![]() |
6 | 1.0 | 2.50E-04 | SLC33A1 | acetyl-CoA transporter activity [MF] |
CG_imr90ipsc_promoter_n_RM_12_58_7 | ![]() |
![]() |
2 | 0.4 | 3.53E-04 | INTS1, EZR, EPB41L4A, PRPF19 | cytoskeleton [CC], extrinsic to membrane [CC], inner cell mass cell proliferation [BP] |
CG_imr90ipsc_promoter_n_RM_12_221_5 | ![]() |
![]() |
4 | 0.8 | 1.28E-04 | DPYS, GSK3B, TWIST1 | thymine binding [MF], canonical Wnt receptor signaling pathway involved in positive regulation of apoptotic process [BP], positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation [BP], cell proliferation involved in heart valve development [BP], uracil binding [MF] |
CG_imr90ipsc_promoter_n_RM_12_139_4 | ![]() |
![]() |
4 | 0.8 | 1.29E-04 | AASS | saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity [MF], saccharopine dehydrogenase (NADP+, L-lysine-forming) activity [MF] |
CG_imr90ipsc_promoter_n_RM_12_4_5 | ![]() |
![]() |
5 | 0.8 | 2.22E-04 | DHCR7, UBE2N, WT1 | 7-dehydrocholesterol reductase activity [MF], postreplication repair [BP], negative regulation of metanephric glomerular mesangial cell proliferation [BP] |
CG_imr90ipsc_promoter_n_RM_12_181_6 | ![]() |
![]() |
4 | 0.6 | 2.52E-04 | HYI, CYBA, GSR | hydroxypyruvate isomerase activity [MF], smooth muscle hypertrophy [BP], negative regulation of glomerular filtration by angiotensin [BP], glutathione-disulfide reductase activity [MF] |
CG_imr90ipsc_promoter_n_RM_12_47_2 | ![]() |
![]() |
4 | 0.6 | 2.88E-04 | LDB1, STAT5B | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [BP], histone H3-K4 acetylation [BP], negative regulation of erythrocyte differentiation [BP] |
CG_imr90ipsc_promoter_n_RM_12_238_3 | ![]() |
![]() |
6 | 1.0 | 2.93E-04 | CEBPA, PCYT2, SLC25A29, PITX2 | superior vena cava morphogenesis [BP], response to vitamin B2 [BP], prolactin secreting cell differentiation [BP], subthalamic nucleus development [BP], ethanolamine-phosphate cytidylyltransferase activity [MF], acyl carnitine transmembrane transporter activity [MF] |
CG_imr90ipsc_promoter_n_RM_12_23_5 | ![]() |
![]() |
5 | 1.0 | 2.35E-04 | LBX1, LEF1 | RNA polymerase II regulatory region sequence-specific DNA binding [MF], eye pigmentation [BP], transcription regulatory region sequence-specific DNA binding [MF] |
CG_imr90ipsc_promoter_n_RM_12_235_8 | ![]() |
![]() |
3 | 0.4 | 4.40E-04 | NGF, SP3, RUNX1, ALG2 | protein glycosylation in endoplasmic reticulum [BP], granulocyte differentiation [BP], positive regulation of nerve growth factor receptor signaling pathway [BP], peripheral nervous system development [BP], positive regulation of progesterone secretion [BP], definitive hemopoiesis [BP] |
CG_imr90ipsc_promoter_n_RM_12_187_7 | ![]() |
![]() |
6 | 0.8 | 3.87E-04 | LBX1 | regulation of transcription from RNA polymerase II promoter involved in spinal cord association neuron specification [BP] |
CG_imr90ipsc_promoter_n_RM_12_224_6 | ![]() |
![]() |
3 | 0.6 | 2.80E-04 | SNCB, CCK, AVP | neuropeptide hormone activity [MF], terminal bouton [CC] |
CG_imr90ipsc_promoter_n_RM_12_155_7 | ![]() |
![]() |
8 | 1.0 | 2.72E-04 | PKD1, FBXO5, TK1, TICAM1 | spindle assembly involved in female meiosis I [BP], metanephric distal tubule morphogenesis [BP], positive regulation of protein binding [BP], fetal process involved in parturition [BP], inhibition of mitotic anaphase-promoting complex activity [BP] |
CG_imr90ipsc_promoter_n_RM_12_45_8 | ![]() |
![]() |
5 | 0.8 | 1.85E-04 | MYBBP1A | NLS-dependent protein nuclear import complex [CC] |
CG_imr90ipsc_promoter_n_RM_12_16_2 | ![]() |
![]() |
2 | 0.4 | 3.44E-04 | COL12A1, SHANK1, FLNA | habituation [BP], collagen type XII [CC], extracellular vesicular exosome [CC], determination of affect [BP], somatostatin receptor binding [MF] |
CG_imr90ipsc_promoter_n_RM_12_46_10 | ![]() |
![]() |
3 | 0.6 | 3.07E-04 | SIK1 | regulation of myotube differentiation [BP] |
CG_imr90ipsc_promoter_n_RM_12_49_4 | ![]() |
![]() |
2 | 0.4 | 3.20E-04 | EPC1, COL12A1, ACVR1C, NKX2-5, ARHGEF11 | regulation of growth [BP], proepicardium development [BP], positive regulation of voltage-gated calcium channel activity [BP], collagen type XII [CC], negative regulation of chorionic trophoblast cell proliferation [BP], positive regulation of transcription via serum response element binding [BP], striated muscle contraction [BP], Purkinje myocyte differentiation [BP], apoptotic process involved in heart morphogenesis [BP], atrioventricular node cell development [BP], nodal binding [MF], right ventricular cardiac muscle tissue morphogenesis [BP], atrioventricular node cell fate commitment [BP] |
CG_imr90ipsc_promoter_n_RM_12_159_5 | ![]() |
![]() |
3 | 0.6 | 4.60E-04 | LDB1 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [BP], histone H3-K4 acetylation [BP], positive regulation of hemoglobin biosynthetic process [BP] |
CG_imr90ipsc_promoter_n_RM_12_132_3 | ![]() |
![]() |
3 | 0.6 | 7.99E-05 | CEBPA, INSRR, CTSH | HLA-A specific activating MHC class I receptor activity [MF], response to vitamin B2 [BP], cellular response to alkalinity [BP] |
CG_imr90ipsc_promoter_n_RM_12_204_8 | ![]() |
![]() |
3 | 0.6 | 1.61E-04 | FGFR2, HS6ST1, PHOX2A | midbrain development [BP], lung alveolus development [BP] |
CG_imr90ipsc_promoter_n_RM_12_35_6 | ![]() |
![]() |
3 | 0.6 | 3.27E-04 | MSRB1, LUZP1, E2F8, TBX20 | neural fold bending [BP], embryonic heart tube elongation [BP], cell cycle comprising mitosis without cytokinesis [BP], methionine-R-sulfoxide reductase activity [MF] |
CG_imr90ipsc_promoter_n_RM_12_41_9 | ![]() |
![]() |
4 | 0.8 | 2.02E-04 | UGGT2 | UDP-glucosylation [BP] |
CG_imr90ipsc_promoter_n_RM_12_88_9 | ![]() |
![]() |
7 | 1.0 | 3.83E-04 | ABCA2 | regulation of intracellular cholesterol transport [BP] |
CG_imr90ipsc_promoter_n_RM_14_20_3 | ![]() |
![]() |
3 | 0.4 | 3.03E-04 | TNK2, SMAD7, HID1 | Grb2-EGFR complex [CC], transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity [MF], Golgi medial cisterna [CC], response to brefeldin A [BP], extrinsic to Golgi membrane [CC] |
CG_imr90ipsc_promoter_n_RM_12_130_2 | ![]() |
![]() |
2 | 0.4 | 3.25E-04 | ICMT | protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity [MF] |
CG_imr90ipsc_promoter_n_RM_12_236_4 | ![]() |
![]() |
3 | 0.6 | 3.65E-04 | CDKN2A, PPAP2B, DNASE1L3, PRKDC, ZFP36L1 | protein destabilization [BP], germ cell migration [BP], regulation of protein stability [BP], T cell differentiation in thymus [BP], apoptotic DNA fragmentation [BP] |
CG_imr90ipsc_promoter_n_RM_12_231_4 | ![]() |
![]() |
2 | 0.4 | 2.34E-04 | HOXA1, HOXA5 | optokinetic behavior [BP], abducens nerve formation [BP], cell-cell signaling involved in mammary gland development [BP] |
CG_imr90ipsc_promoter_n_RM_12_104_4 | ![]() |
![]() |
2 | 0.4 | 1.39E-04 | LCAT | phosphatidylcholine-sterol O-acyltransferase activity [MF] |
CG_imr90ipsc_promoter_n_RM_12_223_4 | ![]() |
![]() |
3 | 0.6 | 1.77E-04 | SIN3A, NKX2-2 | ventral spinal cord interneuron fate determination [BP], response to methylglyoxal [BP], type B pancreatic cell fate commitment [BP], negative regulation of histone H3-K27 acetylation [BP] |
CG_imr90ipsc_promoter_n_RM_12_71_5 | ![]() |
![]() |
7 | 0.8 | 2.59E-04 | DLX2 | olfactory bulb development [BP] |
CG_imr90ipsc_promoter_n_RM_14_18_2 | ![]() |
![]() |
7 | 1.0 | 4.08E-04 | ALG2 | protein glycosylation in endoplasmic reticulum [BP], GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity [MF] |
CG_imr90ipsc_promoter_n_RM_12_85_3 | ![]() |
![]() |
4 | 0.8 | 2.49E-04 | MEX3D, IRF7, SOCS1 | mRNA localization resulting in posttranscriptional regulation of gene expression [BP], regulation of MyD88-independent toll-like receptor signaling pathway [BP], regulation of type I interferon-mediated signaling pathway [BP] |
CG_imr90ipsc_promoter_n_RM_12_37_7 | ![]() |
![]() |
5 | 0.8 | 3.21E-04 | PROM1, CIB2 | photoreceptor cell maintenance [BP] |
CG_imr90ipsc_promoter_n_RM_12_102_6 | ![]() |
![]() |
6 | 1.0 | 1.83E-04 | RARRES2, GLI3 | embryonic digestive tract development [BP] |
CG_imr90ipsc_promoter_n_RM_12_127_5 | ![]() |
![]() |
3 | 0.6 | 2.15E-04 | TBX18 | negative regulation of canonical Wnt receptor signaling pathway involved in neural plate anterior/posterior pattern formation [BP] |
CG_imr90ipsc_promoter_n_RM_12_120_8 | ![]() |
![]() |
6 | 1.0 | 5.26E-04 | SP3 | monocyte differentiation [BP], natural killer cell differentiation [BP] |
CG_imr90ipsc_promoter_n_RM_12_191_6 | ![]() |
![]() |
4 | 0.6 | 1.08E-04 | GPLD1, CD34, TXN | GPI anchor release [BP], cellular response to triglyceride [BP], cellular response to drug [BP], extracellular vesicular exosome assembly [BP], negative regulation of cellular response to hypoxia [BP], response to thyroxine stimulus [BP], negative regulation of cellular response to heat [BP], positive regulation of glial cell line-derived neurotrophic factor secretion [BP] |
CG_imr90ipsc_promoter_n_RM_12_170_5 | ![]() |
![]() |
3 | 0.6 | 3.91E-04 | POLQ, POLD4 | DNA-directed DNA polymerase activity [MF] |
CG_imr90ipsc_promoter_n_RM_12_48_4 | ![]() |
![]() |
2 | 0.4 | 2.82E-04 | ERCC2, G6PD, PPAT, CREBBP, ECHDC1, MKI67 | methylmalonyl-CoA decarboxylase activity [MF], erythrocyte maturation [BP], amidophosphoribosyltransferase activity [MF], 4 iron, 4 sulfur cluster binding [MF], organ regeneration [BP], negative regulation of protein glutathionylation [BP], cellular response to stress [BP] |
CG_imr90ipsc_promoter_n_RM_12_83_2 | ![]() |
![]() |
4 | 0.8 | 2.49E-04 | TXNDC16, PTGES2 | cell redox homeostasis [BP] |
CG_imr90ipsc_promoter_n_RM_12_78_5 | ![]() |
![]() |
5 | 0.8 | 2.62E-04 | GNB1 | energy reserve metabolic process [BP] |
CG_imr90ipsc_promoter_n_RM_14_17_1 | ![]() |
![]() |
5 | 0.8 | 4.50E-04 | PPA2, SIX4 | diphosphate metabolic process [BP], myoblast migration [BP] |
CG_imr90ipsc_promoter_n_RM_12_3_4 | ![]() |
![]() |
4 | 0.8 | 3.14E-04 | GCLM, HYAL2, RRAS, CDK6, GPX6, BCL2, SMURF1 | kidney development [BP], hematopoietic progenitor cell differentiation [BP], regulation of mitochondrial membrane potential [BP], response to oxidative stress [BP], glomerulus development [BP], ossification [BP], regulation of mitochondrial depolarization [BP], negative regulation of ossification [BP], negative regulation of cell migration [BP], response to UV-B [BP] |
CG_imr90ipsc_promoter_n_RM_12_145_8 | ![]() |
![]() |
8 | 1.0 | 3.07E-04 | RIMS3, CDK5 | neurotransmitter transport [BP], synaptic vesicle exocytosis [BP] |
CG_imr90ipsc_promoter_n_RM_12_134_2 | ![]() |
![]() |
3 | 0.6 | 2.56E-04 | KDELR1, INTS1 | KDEL sequence binding [MF], U2 snRNA 3'-end processing [BP] |
CG_imr90ipsc_promoter_n_RM_12_53_2 | ![]() |
![]() |
6 | 1.0 | 3.40E-04 | WARS, CARS2 | tRNA aminoacylation for protein translation [BP] |
CG_imr90ipsc_promoter_n_RM_12_80_7 | ![]() |
![]() |
3 | 0.6 | 3.80E-04 | GNG5, SHANK1, GNG12, TSHZ3, HPS4 | synaptic transmission [BP], somatostatin receptor binding [MF], ureteric peristalsis [BP], habituation [BP], positive regulation of eye pigmentation [BP], determination of affect [BP], heterotrimeric G-protein complex [CC], cellular response to glucagon stimulus [BP] |
CG_imr90ipsc_promoter_n_RM_12_57_4 | ![]() |
![]() |
4 | 0.8 | 2.89E-04 | HOXB6, HOXA1, ARX | embryonic skeletal system morphogenesis [BP], optokinetic behavior [BP], embryonic olfactory bulb interneuron precursor migration [BP], globus pallidus development [BP], semicircular canal formation [BP], abducens nerve formation [BP] |
CG_imr90ipsc_promoter_n_RM_12_125_5 | ![]() |
![]() |
3 | 0.6 | 3.82E-04 | TRMT112 | peptidyl-glutamine methylation [BP] |
CG_imr90ipsc_promoter_n_RM_12_129_6 | ![]() |
![]() |
6 | 0.8 | 2.63E-04 | ATP5E, ZER1 | proton-transporting ATPase activity, rotational mechanism [MF] |
CG_imr90ipsc_promoter_n_RM_12_94_7 | ![]() |
![]() |
5 | 1.0 | 2.02E-04 | FGFR2, TNS3 | fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow [BP], coronal suture morphogenesis [BP], fibroblast growth factor receptor signaling pathway involved in hemopoiesis [BP], lung alveolus development [BP], fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow [BP] |
CG_imr90ipsc_promoter_n_RM_14_23_4 | ![]() |
![]() |
7 | 1.0 | 1.38E-04 | MB21D1, PDF | cyclic-GMP-AMP synthase activity [MF], peptide deformylase activity [MF] |
CG_imr90ipsc_promoter_n_RM_14_13_7 | ![]() |
![]() |
10 | 1.0 | 9.27E-05 | TRUB2, PUS7L | pseudouridine synthase activity [MF], pseudouridine synthesis [BP] |
CG_imr90ipsc_promoter_n_RM_12_149_5 | ![]() |
![]() |
5 | 1.0 | 3.38E-04 | MNX1, CEBPD, NKX2-2 | sequence-specific DNA binding [MF], neuron fate specification [BP], spinal cord motor neuron differentiation [BP] |
CG_imr90ipsc_promoter_n_RM_12_96_6 | ![]() |
![]() |
4 | 0.8 | 4.24E-04 | TAL1 | Lsd1/2 complex [CC] |
CG_imr90ipsc_promoter_n_RM_12_87_2 | ![]() |
![]() |
3 | 0.6 | 3.49E-04 | DCAKD, GBX2 | dephospho-CoA kinase activity [MF], rhombomere 2 development [BP] |
CG_imr90ipsc_promoter_n_RM_14_21_2 | ![]() |
![]() |
2 | 0.4 | 1.60E-04 | AXIN1, MAP3K5, TAX1BP3 | activation of JUN kinase activity [BP], beta-catenin binding [MF] |
CG_imr90ipsc_promoter_n_RM_12_105_5 | ![]() |
![]() |
4 | 0.6 | 3.33E-04 | PABPC1, MAGI1, EML2 | protein C-terminus binding [MF] |
CG_imr90ipsc_promoter_n_RM_12_216_6 | ![]() |
![]() |
3 | 0.6 | 3.49E-04 | ITGB5, TNIP2, AKT1, MTSS1, SOCS1, PTK2 | growth hormone receptor signaling pathway [BP], fat cell differentiation [BP], response to fluid shear stress [BP], protein kinase binding [MF], renal tubule morphogenesis [BP], cell leading edge [CC] |
CG_imr90ipsc_promoter_n_RM_12_59_5 | ![]() |
![]() |
4 | 0.8 | 3.66E-04 | USH1G, WDR1, THRB | sensory perception of sound [BP] |
CG_imr90ipsc_promoter_n_RM_12_128_2 | ![]() |
![]() |
3 | 0.6 | 1.42E-04 | TRMT61B, BIN3 | mitochondrial tRNA methylation [BP], barrier septum assembly [BP] |
CG_imr90ipsc_promoter_n_RM_12_166_8 | ![]() |
![]() |
4 | 0.8 | 2.29E-04 | ANKLE2, ARSJ, MOCS2, ACER1, SLC5A6, PLA2G16 | biotin transport [BP], mitotic nuclear envelope reassembly [BP], small molecule metabolic process [BP], pantothenate transmembrane transport [BP] |
CG_imr90ipsc_promoter_n_RM_12_90_4 | ![]() |
![]() |
7 | 1.0 | 2.47E-04 | TBX15, TBX18 | RNA polymerase II transcription corepressor activity [MF] |
CG_imr90ipsc_promoter_n_RM_14_27_3 | ![]() |
![]() |
7 | 1.0 | 3.63E-04 | RUNX1, SP3 | liver development [BP], regulation of hair follicle cell proliferation [BP], granulocyte differentiation [BP], definitive hemopoiesis [BP], positive regulation of progesterone secretion [BP] |
CG_imr90ipsc_promoter_n_RM_12_19_11 | ![]() |
![]() |
5 | 1.0 | 2.98E-04 | ACTN1, ITGB5, PEAK1, SDC1 | focal adhesion [CC] |
CG_imr90ipsc_promoter_n_RM_12_55_4 | ![]() |
![]() |
3 | 0.6 | 2.48E-04 | DEAF1, SOX18 | blood vessel endothelial cell migration [BP], regulation of mammary gland epithelial cell proliferation [BP] |
CG_imr90ipsc_promoter_n_RM_12_156_5 | ![]() |
![]() |
4 | 0.8 | 2.46E-04 | UROC1, HDDC3, LIF | urocanate hydratase activity [MF], positive regulation of histone H3-K27 acetylation [BP], RNA polymerase II transcription factor recruiting transcription factor activity [MF], positive regulation of protein localization to nucleus [BP], guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity [MF] |
CG_imr90ipsc_promoter_n_RM_12_160_5 | ![]() |
![]() |
6 | 1.0 | 3.24E-04 | PTK2, CDK6, SFRP1 | stromal-epithelial cell signaling involved in prostate gland development [BP], negative regulation of osteoblast differentiation [BP], convergent extension involved in somitogenesis [BP], regulation of osteoblast differentiation [BP], osteoblast differentiation [BP], hematopoietic progenitor cell differentiation [BP], negative regulation of myeloid cell differentiation [BP], cell dedifferentiation [BP], positive regulation of fibroblast apoptotic process [BP], negative regulation of canonical Wnt receptor signaling pathway involved in controlling type B pancreatic cell proliferation [BP], netrin-activated signaling pathway [BP], regulation of focal adhesion assembly [BP], positive regulation of cell-matrix adhesion [BP], positive regulation of cell adhesion [BP], hematopoietic stem cell differentiation [BP] |
CG_imr90ipsc_promoter_n_RM_12_70_5 | ![]() |
![]() |
7 | 0.8 | 4.49E-04 | NEUROG1, ASCL2 | E-box binding [MF] |
CG_imr90ipsc_promoter_n_RM_12_44_7 | ![]() |
![]() |
5 | 1.0 | 3.43E-04 | TACR3 | tachykinin receptor activity [MF] |
CG_imr90ipsc_promoter_n_RM_14_25_3 | ![]() |
![]() |
7 | 1.0 | 1.54E-04 | TRMT61B, SLC27A5 | mitochondrial tRNA methylation [BP], cholate-CoA ligase activity [MF] |
CG_imr90ipsc_promoter_n_RM_12_206_10 | ![]() |
![]() |
3 | 0.6 | 3.64E-04 | NR2C1, NOTCH1, ZSCAN10, CEBPD, NR2F6 | steroid hormone receptor activity [MF], Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [BP], sequence-specific DNA binding transcription factor activity [MF], regulation of extracellular matrix assembly [BP], sequence-specific DNA binding [MF], transcription initiation from RNA polymerase II promoter [BP], venous endothelial cell differentiation [BP] |
CG_imr90ipsc_promoter_n_RM_12_237_4 | ![]() |
![]() |
6 | 1.0 | 3.87E-04 | B3GALNT1, AGO2, HBEGF | endoribonuclease activity, cleaving siRNA-paired mRNA [MF], negative regulation of elastin biosynthetic process [BP], galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity [MF] |
CG_imr90ipsc_promoter_n_RM_12_147_13 | ![]() |
![]() |
5 | 1.0 | 5.13E-04 | MNX1, NKX2-4, CREBZF, AHDC1, THSD7A, NUP62, SOX10, CALCOCO1, CSRNP1, MAMSTR, PHIP, FBXO21, ABCB6, ZNF784, NEUROG1, KDM2B, POU3F1, C1QL3, C1QL4, WDR33, HOXB3, AMBRA1, RXRG, HOXB5, TFAP2A, FOXL2, UBA3, CNTFR, MEX3C, NFIB, ZNF521, GFI1, HIRA, GSK3B, FZD8, SLC25A21, GNA13, HOXA1, GAS1, ZFHX3 | muscle organ development [BP], face development [BP], brain development [BP], embryonic cranial skeleton morphogenesis [BP], multicellular organismal development [BP], embryonic eye morphogenesis [BP], nervous system development [BP], skeletal system morphogenesis [BP], regulation of transcription, DNA-dependent [BP], sequence-specific DNA binding transcription factor activity [MF], neuron differentiation [BP], regulation of neuron differentiation [BP], pattern specification process [BP], intracellular membrane-bounded organelle [CC], nerve development [BP], cell differentiation [BP], sequence-specific DNA binding RNA polymerase II transcription factor activity [MF], anatomical structure morphogenesis [BP], regulation of neurogenesis [BP], positive regulation of transcription, DNA-dependent [BP], transcription regulatory region DNA binding [MF], organ morphogenesis [BP], positive regulation of transcription from RNA polymerase II promoter [BP], skeletal muscle organ development [BP], outer ear morphogenesis [BP], regulation of transcription from RNA polymerase II promoter [BP], embryonic skeletal system morphogenesis [BP], DNA binding [MF], RNA polymerase II transcription factor binding transcription factor activity [MF], collagen [CC], sequence-specific DNA binding [MF], negative regulation of transcription, DNA-dependent [BP], positive regulation of gene expression [BP], eye morphogenesis [BP], neural tube development [BP], embryo development [BP], transcription from RNA polymerase II promoter [BP], cellular nitrogen compound metabolic process [BP], rhombomere development [BP] |
CG_imr90ipsc_promoter_n_RM_12_40_5 | ![]() |
![]() |
4 | 0.8 | 2.39E-04 | JSRP1 | sarcoplasmic reticulum membrane [CC] |
CG_imr90ipsc_promoter_n_RM_12_6_6 | ![]() |
![]() |
5 | 1.0 | 3.64E-04 | CEBPA, GAS2L2, PTGS2 | response to lithium ion [BP], response to glucocorticoid stimulus [BP], negative regulation of microtubule depolymerization [BP] |
CG_imr90ipsc_promoter_n_RM_12_222_5 | ![]() |
![]() |
3 | 0.6 | 3.53E-04 | HDAC2, SALL1, NCOR1, VAX1, SETD7 | Sin3 complex [CC], protein deacetylase activity [MF], chromatin modification [BP], embryonic digit morphogenesis [BP], regulation of protein deacetylation [BP], negative regulation of transcription from RNA polymerase II promoter [BP], chromatin DNA binding [MF], brain development [BP], histone deacetylase complex [CC], transcriptional repressor complex [CC], histone deacetylation [BP], regulation of glycolysis by negative regulation of transcription from RNA polymerase II promoter [BP], histone deacetylase activity [MF], chromosome [CC], NuRD complex [CC], chromatin binding [MF], inductive cell-cell signaling [BP], regulation of neural precursor cell proliferation [BP] |
CG_imr90ipsc_promoter_n_RM_12_158_3 | ![]() |
![]() |
3 | 0.6 | 2.07E-04 | SIGMAR1, SIN3A, PDGFRB | cell migration involved in coronary angiogenesis [BP], response to methylglyoxal [BP], ergosterol biosynthetic process [BP], negative regulation of histone H3-K27 acetylation [BP] |
CG_imr90ipsc_promoter_n_RM_16_6_1 | ![]() |
![]() |
2 | 0.4 | 3.19E-05 | ZNF626, ZNF708, ZNF737, ZNF100, ZNF99 | transcription, DNA-dependent [BP], DNA binding [MF], regulation of transcription, DNA-dependent [BP], zinc ion binding [MF] |
CG_imr90ipsc_promoter_n_RM_12_157_7 | ![]() |
![]() |
8 | 1.0 | 3.74E-04 | TOX, ZNF746, FZD8, SIX1, ZNF34, PAX6, SALL1, ZNF395, ZNF337 | ubiquitin protein ligase binding [MF], DNA binding [MF] |
CG_imr90ipsc_promoter_n_RM_12_89_4 | ![]() |
![]() |
2 | 0.4 | 2.22E-04 | SIAE, MYO1C, VIMP | regulation of nitric oxide metabolic process [BP], myosin I complex [CC], sialate O-acetylesterase activity [MF], positive regulation of vascular endothelial growth factor signaling pathway [BP] |
CG_imr90ipsc_promoter_n_RM_16_4_1 | ![]() |
![]() |
3 | 0.6 | 9.97E-04 | AURKB | cleavage furrow formation [BP], spindle midzone assembly involved in mitosis [BP], chromosome passenger complex [CC] |
CG_imr90ipsc_promoter_n_RM_12_218_4 | ![]() |
![]() |
8 | 1.0 | 4.77E-04 | CD34, TXN, POU4F1 | glomerular endothelium fenestra [CC], extracellular vesicular exosome assembly [BP], negative regulation of cellular response to hypoxia [BP], response to thyroxine stimulus [BP], proprioception involved in equilibrioception [BP], negative regulation of cellular response to heat [BP], positive regulation of glial cell line-derived neurotrophic factor secretion [BP] |